Fundraising FoxNorthpond Ventures — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue.
BiotechDigital HealthHealthtechMedical DevicesMadison, US
Jonathan Oliner(Executive Officer)inManeesh Arora(Founder)inMichelle B. Arora(Director)Terrence P. Brady(Executive Officer)
Co-investorsARCH Venture PartnersSands Capital Ventures
Phia is an AI shopping assistant that compares prices across the web and secondhand marketplaces so shoppers can build their closet at the best price.
New York, US
Sophia Kianni(Founder)inPhoebe Gates(Founder)in
BoardAnnie Case(Director)in
Co-investorsCold Start VenturesDuke Capital PartnersKleiner PerkinsMento vcNotable CapitalScribble Ventures+2 more
Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices.
AI & Machine LearningBiotechDeep TechHardwareHealthtechSan Diego, US
Daniel G. Gibson(Executive Officer)inTodd R. Nelson(Executive Officer, Director)Eric Esser(Executive Officer)inWilliam F. Snider(Director)Andrea L. Jackson(Director)inChristine A. Tsingos(Director)
Co-investorsNovalis LifeSciences
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Merge Bio TherapeuticsCove SodaFanable
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.